1Hoogeveen E K，Arterioscler Thromb Vasc Biol，1998年，18卷，133页
2Aronow W S，Am J Cardiol，1997年，79卷，1432页
3Boushey C J，JAMA，1995年，274卷，1049页
4Nishinaga M，J Clin Invest，1993年，92卷，381页
5Taylor L Mjr，J Vasc Surg，1991年，13卷，128页
6Starkdbaum G，J Clin Invest，1986年，77卷，1370页
7Rothwell PM, Coull AJ, Silver LE, et al. Population-based study of event-rate, incidence, case fatality and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet, 2005, 366:1773 - 1783.
8Goldstein LB, Rothwell PM. Primary prevention and health services delivery. Stroke, 2007, 38:222 -224.
9Bonaa KH, Njolstad I, Ueland PM, et al; NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med, 2006, 354:1578 - 1588.
10Meissner I,Khanderia BK, Heit JA, et al. Patent foramen ovale: innocent or guilty?. Evidence from a prospective population-based study. J Am Coll Cardiol, 2006, 47:440 -445.
2Sun Y, Lu C J, Chen Rc, et al. Lack of associatiaon between total serum homocysteine and extracranial cerebral flow [J]. J Formos Med Assoc ,2010,109(4) :278-286.
